MS finding supports T-cell targeting; ALS gene a boost for antioxidants

Encouraging discoveries

The discovery of the dominant immune response that causes multiple sclerosis, announced last week by researchers at Neurocrine Biosciences Inc. and Stanford University, is validating an approach taken by several biotech companies. ...